Feasibility of Implementing a Comprehensive Warfarin Pharmacogenetics Service-Reference-Cited by-同舟云学术

Feasibility of Implementing a Comprehensive Warfarin Pharmacogenetics Service

Published:2013-07-17 Issue:11 Volume:33 Page:1156-1164
ISSN:0277-0008
Container-title:Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
language:en
Short-container-title:Pharmacotherapy

Author:

Nutescu Edith A.¹,Drozda Katarzyna¹,Bress Adam P.¹,Galanter William L.¹²,Stevenson James¹,Stamos Thomas D.³,Desai Ankit A.³⁴,Duarte Julio D.¹⁴,Gordeuk Victor⁵,Peace David⁵,Kadkol ShriHari S.⁶,Dodge Carol⁶,Saraf Santosh⁵,Garofalo John¹,Krishnan Jerry A.⁷⁸,Garcia Joe G. N.⁴⁷⁸,Cavallari Larisa H.¹

Affiliation:

1. Department of Pharmacy Practice; University of Illinois at Chicago; Chicago IL

2. Department of Medicine; General Internal Medicine; University of Illinois at Chicago; Chicago IL

3. Department of Medicine, Cardiology; University of Illinois at Chicago; Chicago IL

4. Department of Medicine; Institute for Personalized Respiratory Medicine; University of Illinois at Chicago; Chicago IL

5. Department of Medicine, Hematology/Oncology; University of Illinois at Chicago; Chicago IL

6. Department of Pathology; Section of Pulmonary, Critical Care, Sleep and Allergy; University of Illinois at Chicago; Chicago IL

7. Section of Pulmonary, Critical Care, Sleep and Allergy; University of Illinois at Chicago; Chicago IL

8. Office of the Vice President for Health Affairs; University of Illinois Hospital & Health Sciences System; Chicago IL

Publisher

Wiley

Subject

Pharmacology (medical)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/phar.1329/fullpdf

Reference17 articles.

1. Emergency hospitalizations for adverse drug events in older Americans;Budnitz;N Engl J Med,2011

2. Use of pharmacogenetic and clinical factors to predict the therapeutic dose of warfarin;Gage;Clin Pharmacol Ther,2008

3. Influence of CYP2C9 and VKORC1 on patient response to warfarin: a systematic review and meta-analysis;Jorgensen;PLoS ONE,2012

4. CYP4F2 genetic variant alters required warfarin dose;Caldwell;Blood,2008

5. A genome-wide association study confirms VKORC1, CYP2C9, and CYP4F2 as principal genetic determinants of warfarin dose;Takeuchi;PLoS Genet,2009

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of a Multifaceted Program for Pharmacogenetics Adoption at an Academic Medical Center: Practical Considerations and Lessons Learned;Clinical Pharmacology & Therapeutics;2024-08-21

2. Leveraging QSP Models for MIPD: A Case Study for Warfarin/INR;Clinical Pharmacology & Therapeutics;2024-04-24

3. The Critical Role of Pharmacists in the Clinical Delivery of Pharmacogenetics in the U.S;Pharmacy;2023-09-10

4. Congruence rates for pharmacogenomic noninterruptive alerts;Pharmacogenomics;2023-06

5. Pharmacogenomic panel testing provides insight and enhances medication management in people with HIV;AIDS;2023-05-11